NCT06058377 2026-03-18
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
National Cancer Institute (NCI)
Phase 3 Recruiting
Clinical Trials
9 trialsNCT01334021 2026-03-09
Genetic Testing in Predicting Tumor Response in Patients With Stage I-III HER2 Negative Invasive Breast Cancer
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT06632977 2026-03-04
PREDICT
Alliance for Clinical Trials in Oncology
Phase 2 Recruiting
NCT03233191 2026-03-02
Digital Tomosynthesis Mammography and Digital Mammography in Screening Patients for Breast Cancer
Eastern Cooperative Oncology Group
Phase 3 Active not recruiting
NCT04354675 2026-02-20
Effectiveness of AI Genetic Counseling Program vs In-person Genetic Counseling in Breast Cancer
Case Comprehensive Cancer Center
Phase NA Completed
NCT05028621 2026-02-20
Molecular Basis of Langerhans and Non-Langerhans Cell Histiocytic Neoplasms and Castleman Disease
Case Comprehensive Cancer Center
Phase NA Suspended
NCT05694559 2026-02-19
Connecting Black Families in Houston, Texas to Hereditary Cancer Genetic Counseling, Genetic Testing, and Cascade Testing by Using a Simple Genetic Risk Screening Tool and Telegenetics
M.D. Anderson Cancer Center
Phase NA Recruiting
NCT07377006 2026-02-18
Decision Support Tool to Enhance Germline Genetic Testing for Patients With Prostate Cancer
M.D. Anderson Cancer Center
Phase NA Not yet recruiting
NCT07412028 2026-02-17
ANDROLIPO
Assistance Publique - Hôpitaux de Paris
Phase NA Not yet recruiting